ImpediMed Company Description

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally.

The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications.

It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

ImpediMed Limited

Country	Australia
Founded	1999
Industry	Medical Devices
Sector	Healthcare
Employees	77
CEO	Erik Anderson

Contact Details

Address: 5900 Pasteur Court Carlsbad, California California United States
Phone	760 585 2100

Stock Details

Ticker Symbol	IPD
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000IPD8
SIC Code	3845

Key Executives

Name	Position
Erik Anderson	Chief Executive Officer, MD and Director
McGregor Grant BEc, C.A., FCIS, GAICD	Chief Financial Officer and Executive Director
Scott Long	Senior Vice President of US Sales, Key Accounts, and Renewals
Julie Kuhlken	Senior Director of Marketing
Ashley Munoz	Director of Human Resources
Dr. Steven Chen M.B.A., M.D.	Chief Medical Officer
Leanne Ralph AAICD, ACIS, BBus	Company Secretary